---
title: 4Q 2017 Results and preliminary annual report
description: Moss, 27 February 2018. Gentian Diagnostics AS announces its results for the 4th quarter and 2017 preliminary annual results.
---

Moss, 27 February 2018

Gentian Diagnostics AS announces its results for the 4th quarter and 2017 preliminary annual results. The highlights include:

- 11% growth in sales revenue compared to 4Q16, 14 % y/y despite loss of our largest distributor
- Increase in sales of fCAL turbo continues
- Favorable development for Cystatin C in China

 

**Please find the [report enclosed](https://www.gentian.com/hubfs/2017-4Q-Interim-report.pdf). **

The report will also be made available on [www.gentian.com](https://www.gentian.com).

**For further information, please contact: **

Bård Sundrehagen CEO, Gentian Diagnostics  
E-mail: [bard.sundrehagen@gentian.no](mailto:bard.sundrehagen@gentian.no)  
Cell Phone: +47 924 14 117

Njaal Kind CFO, Gentian Diagnostics  
E-mail: [njaal.kind@gentian.no](mailto:njaal.kind@gentian.no)  
Cell Phone. +47 919 06 525

 

**MeldingsID:**  445248

### You may also read

[Jul 02, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/4q-2017-results-preliminary-annual-report#)

##### [Gentian Diagnostics: Invitation to presentation of second quarter results](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-to-presentation-of-second-quarter-results-1)

Gentian Diagnostics ASA will present its second quarter 2026 results on 9 July 2026 at 09.00 CEST. The..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-to-presentation-of-second-quarter-results-1)

[Jun 24, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/4q-2017-results-preliminary-annual-report#)

##### [ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT](https://www.gentian.com/investor-relations-stock-information/investors-news/essange-reagents-and-gentian-diagnostics-announce-collaboration-agreement)

Amsterdam / Moss, 24 June 2026 ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/essange-reagents-and-gentian-diagnostics-announce-collaboration-agreement)

[May 29, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/4q-2017-results-preliminary-annual-report#)

##### [Mandatory notification of trade](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-1780055230560)

Moss, 29 May 2026 Gentian Diagnostics ASA ("Gentian") has today been notified that the following transaction..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-1780055230560)